openPR Logo
Press release

EMEA (Europe, Middle East and Africa) Insulin Glargine Market Report 2017

05-26-2017 08:24 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: QYresearchreports

Market Research Reports

Market Research Reports

Qyresearchreports include new market research report "EMEA (Europe, Middle East and Africa) Insulin Glargine Market Report 2017" to its huge collection of research reports.

In this report, the EMEA Insulin Glargine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (M ml), revenue (Million USD), market share and growth rate of Insulin Glargine for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Insulin Glargine market competition by top manufacturers/players, with Insulin Glargine sales volume (M ml), price (USD/ml), revenue (Million USD) and market share for each manufacturer/player; the top players including
Sanofi-Aventis
Ganlee
Biocon
...

Enter your information below to receive a sample copy of this report @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1044628&type=E

On the basis of product, this report displays the sales volume (M ml), revenue (Million USD), product price (USD/ml), market share and growth rate of each type, primarily split into
Single Dose Vial
Pre-filled Syringe

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (M ml), market share and growth rate of Insulin Glargine for each application, including
Treat Type 1 Diabetes
Treat Type 2 Diabetes

Browse Market Research Report @ http://www.qyresearchreports.com/report/emea-europe-middle-east-and-africa-insulin-glargine-market-report-2017.htm

Table of Contents

1 Insulin Glargine Overview
1.1 Product Overview and Scope of Insulin Glargine
1.2 Classification of Insulin Glargine
1.2.1 EMEA Insulin Glargine Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Insulin Glargine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Single Dose Vial
1.2.4 Pre-filled Syringe
1.3 EMEA Insulin Glargine Market by Application/End Users
1.3.1 EMEA Insulin Glargine Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Treat Type 1 Diabetes
1.3.3 Treat Type 2 Diabetes
1.4 EMEA Insulin Glargine Market by Region
1.4.1 EMEA Insulin Glargine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Insulin Glargine (2012-2022)
1.5.1 EMEA Insulin Glargine Sales and Growth Rate (2012-2022)
1.5.2 EMEA Insulin Glargine Revenue and Growth Rate (2012-2022)

2 EMEA Insulin Glargine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Insulin Glargine Market Competition by Players/Manufacturers
2.1.1 EMEA Insulin Glargine Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Insulin Glargine Revenue and Share by Players (2012-2017)
2.1.3 EMEA Insulin Glargine Sale Price by Players (2012-2017)
2.2 EMEA Insulin Glargine (Volume and Value) by Type/Product Category
2.2.1 EMEA Insulin Glargine Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Insulin Glargine Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Insulin Glargine Sale Price by Type (2012-2017)
2.3 EMEA Insulin Glargine (Volume) by Application
2.4 EMEA Insulin Glargine (Volume and Value) by Region
2.4.1 EMEA Insulin Glargine Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Insulin Glargine Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Insulin Glargine Sales Price by Region (2012-2017)

3 Europe Insulin Glargine (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Insulin Glargine Sales and Value (2012-2017)
3.1.1 Europe Insulin Glargine Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Insulin Glargine Revenue and Growth Rate (2012-2017)
3.2 Europe Insulin Glargine Sales and Market Share by Type
3.3 Europe Insulin Glargine Sales and Market Share by Application
3.4 Europe Insulin Glargine Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Insulin Glargine Sales Volume by Countries (2012-2017)
3.4.2 Europe Insulin Glargine Revenue by Countries (2012-2017)
3.4.3 Germany Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.4 France Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.5 UK Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.6 Russia Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.7 Italy Insulin Glargine Sales and Growth Rate (2012-2017)
3.4.8 Benelux Insulin Glargine Sales and Growth Rate (2012-2017)

4 Middle East Insulin Glargine (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Insulin Glargine Sales and Value (2012-2017)
4.1.1 Middle East Insulin Glargine Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Insulin Glargine Revenue and Growth Rate (2012-2017)
4.2 Middle East Insulin Glargine Sales and Market Share by Type
4.3 Middle East Insulin Glargine Sales and Market Share by Application
4.4 Middle East Insulin Glargine Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Insulin Glargine Sales Volume by Countries (2012-2017)
4.4.2 Middle East Insulin Glargine Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Insulin Glargine Sales and Growth Rate (2012-2017)
4.4.4 Israel Insulin Glargine Sales and Growth Rate (2012-2017)
4.4.5 UAE Insulin Glargine Sales and Growth Rate (2012-2017)
4.4.6 Iran Insulin Glargine Sales and Growth Rate (2012-2017)

5 Africa Insulin Glargine (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Insulin Glargine Sales and Value (2012-2017)
5.1.1 Africa Insulin Glargine Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Insulin Glargine Revenue and Growth Rate (2012-2017)
5.2 Africa Insulin Glargine Sales and Market Share by Type
5.3 Africa Insulin Glargine Sales and Market Share by Application
5.4 Africa Insulin Glargine Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Insulin Glargine Sales Volume by Countries (2012-2017)
5.4.2 Africa Insulin Glargine Revenue by Countries (2012-2017)
5.4.3 South Africa Insulin Glargine Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Insulin Glargine Sales and Growth Rate (2012-2017)
5.4.5 Egypt Insulin Glargine Sales and Growth Rate (2012-2017)
5.4.6 Algeria Insulin Glargine Sales and Growth Rate (2012-2017)

6 EMEA Insulin Glargine Manufacturers/Players Profiles and Sales Data
6.1 Sanofi-Aventis
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Insulin Glargine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Ganlee
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Insulin Glargine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Biocon
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Insulin Glargine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview

QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYReseachReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EMEA (Europe, Middle East and Africa) Insulin Glargine Market Report 2017 here

News-ID: 552082 • Views:

More Releases from QYresearchreports

Global Oilfield Communication Equipment Market Latest Achievements and Opportunities by Key Vendors - Alcatel-Lucent, ERF Wireless, Harris Caprock
Global Oilfield Communication Equipment Market Latest Achievements and Opportuni …
Qyresearchreports include new market research report Global Oilfield Communication Equipment Market Insights, Forecast to 2025 to its huge collection of research reports. The Oilfield Communication Equipment market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to
Global Power Over Ethernet (POE) Lighting Market : Key Growth Factors and Forecast 2025 | Cisco Systems, Cree, Philips Lighting, Molex, NuLEDs
Global Power Over Ethernet (POE) Lighting Market : Key Growth Factors and Foreca …
Qyresearchreports include new market research report Global Power Over Ethernet (POE) Lighting Market Insights, Forecast to 2025 to its huge collection of research reports. This report presents the worldwide Power Over Ethernet (POE) Lighting market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities
Global Automatic Palletizer and Depalletizer Market to be at Forefront by 2025 | ABB, Columbia Machine, FANUC, KUKA
Global Automatic Palletizer and Depalletizer Market to be at Forefront by 2025 | …
Qyresearchreports include new market research report Global Automatic Palletizer and Depalletizer Market Insights, Forecast to 2025 to its huge collection of research reports. Automatic palletizer and depalletizer is a machine that enables automatic stacking of goods and products. It also enables the depalletizing or unloading of goods. The rising consumer income and European Central Bank (ECB) bond-buying program will influence the buying pattern of consumers in EMEA and will result in
Global Weather Forecasting Equipment Market Advancement Analysis and Precise Outlook: Vaisala (Finland), Sutron Corporation (US), Campbell Scientific (US)
Global Weather Forecasting Equipment Market Advancement Analysis and Precise Out …
Qyresearchreports include new market research report Global Weather Forecasting Equipment Market Insights, Forecast to 2025 to its huge collection of research reports. The Weather Forecasting Equipment market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Bluetooth connected smart insulin pens represent the future of insulin delivery …
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through the
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin
Insulin Drug and Delivery Technologies Market Report 2018: Segmentation by Produ …
Global Insulin Drug and Delivery Technologies market research report provides company profile for Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
09-06-2017 | Health & Medicine
MRRSE
Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effectiv …
By connectivity, the Bluetooth connected smart insulin pen segment is expected to account for a value share of US$ 0.276 Mn in 2017. The segment is expected to reach a little more than US$ 2 Mn by 2027 end, registering the highest CAGR of 23.2% over the forecast period. Bluetooth connected smart insulin pens represent the future of insulin delivery devices. Such devices have an inbuilt Bluetooth connectivity feature allowing
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact